NCT03769116: A reported trial by Sarepta Therapeutics, Inc.
This trial has reported on time, in line with the regulations.
Full data
| Full entry on ClinicalTrials.gov | NCT03769116 |
|---|---|
| Title | A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial for Duchenne Muscular Dystrophy Using SRP-9001 |
| Results Status | Reported |
| ACT or pACT? | This is what FDAAA officially calls an "Applicable Clinical Trial" |
| Start date | Dec. 5, 2018 |
| Completion date | Dec. 8, 2020 |
| Required reporting date | Dec. 8, 2023, midnight |
| Actual reporting date | July 5, 2023 |
| Date last checked at ClinicalTrials.gov | Dec. 12, 2025 |
| Days late | None |